This article is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Never start, stop, or change medication without consulting your prescribing physician.
UpOrbit has no financial relationship with any pharmaceutical company. No affiliate links on this page.
Day 1: The first dose
The most common Day 1 experience with stimulant medication falls into one of three categories:
- "Oh. This is what normal feels like." — A sense of clarity, reduced mental noise, easier task initiation. Some people describe it as hearing their own thoughts clearly for the first time. This doesn't mean the dose is correct yet — but it suggests the medication class is working.
- "I don't notice anything." — The starting dose may be too low. This is intentional — prescribers start low and titrate up. Don't assume the medication doesn't work based on the first dose.
- "I feel wired/anxious/weird." — Some people experience jitteriness, increased heart rate, or anxiety on the first dose, particularly if combined with caffeine. This often settles within 2–3 days as your body adjusts. See caffeine interaction.
Days 2–4: Adjustment
The second and third days are when the "honeymoon effect" may appear or fade. Some people experience a pronounced effect on Day 1 that diminishes slightly by Days 3–4 as neurochemistry begins to adapt. This is normal — the initial response often includes some euphoria or emotional uplift that stabilizes to a more sustainable baseline.
Common experiences during this period:
- Appetite changes. You may not feel hungry during peak medication hours. This is one of the most consistent side effects across stimulant types. Plan meals proactively — eat breakfast before the medication kicks in, have calorie-dense snacks available, eat dinner when appetite returns. See medication and food.
- Sleep changes. Difficulty falling asleep is common in the first week. Your brain is adjusting to different nighttime neurochemistry. Give it time, but if insomnia persists beyond week 1, discuss timing adjustments with your prescriber. See sleep strategies.
- Emotional sensitivity. Some people notice heightened emotions — easier to cry, more moved by music, or more irritable at end-of-dose. Emotional regulation may actually improve overall while being more noticeable at transitions.
- Dry mouth and thirst. Stay hydrated. This is consistently reported and usually manageable.
Days 5–7: Settling in
By the end of the first week, you should have a preliminary sense of whether this medication and dose are in the right ballpark. Some people feel significant benefit by Day 5. Others need dose increases over the following weeks.
Questions worth noting for your follow-up appointment:
- How many hours of noticeable effect do you get?
- Is there a clear point where it "wears off"? How does that feel? See the crash explained.
- Are side effects improving, stable, or worsening?
- On a 1–10 scale, how much has task initiation improved?
- Have you noticed changes in mood, anxiety, or emotional reactivity?
What is NOT normal in the first week
Contact your prescriber if you experience:
- Chest pain, severe palpitations, or shortness of breath
- Severe headache that doesn't resolve
- Extreme mood changes (euphoria followed by depression, or severe irritability)
- Panic attacks or severe anxiety that doesn't improve after Day 2–3
- Inability to sleep at all (not just difficulty, but zero sleep)
- Psychotic symptoms (hearing things, extreme paranoia) — rare but requires immediate attention
The titration process
Your first dose is almost certainly not your final dose. Titration — the process of gradually adjusting medication dose — typically takes 2–6 weeks. Your prescriber will usually schedule a follow-up 1–2 weeks after starting to assess response and adjust.
Good titration is collaborative. Track your responses, side effects, and functional improvements. The goal isn't "no ADHD symptoms" — it's the best balance of benefit vs. side effects. UpOrbit's daily tracking can help you present useful data to your provider.
References
- Cortese et al. (2018). Comparative efficacy of ADHD medications. The Lancet Psychiatry, 5(9).
- Faraone et al. (2021). World Federation of ADHD Consensus. Neurosci Biobehav Rev, 128.